149 related articles for article (PubMed ID: 26386822)
1. Cardiovascular activity of the chiral xanthone derivatives.
Szkaradek N; Rapacz A; Pytka K; Filipek B; Żelaszczyk D; Szafrański P; Słoczyńska K; Marona H
Bioorg Med Chem; 2015 Oct; 23(20):6714-24. PubMed ID: 26386822
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and preliminary evaluation of pharmacological properties of some piperazine derivatives of xanthone.
Szkaradek N; Rapacz A; Pytka K; Filipek B; Siwek A; Cegła M; Marona H
Bioorg Med Chem; 2013 Jan; 21(2):514-22. PubMed ID: 23245804
[TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmic, hypotensive and α1-adrenolytic properties of new 2-methoxyphenylpiperazine derivatives of xanthone.
Rapacz A; Pytka K; Sapa J; Kubacka M; Filipek B; Szkaradek N; Marona H
Eur J Pharmacol; 2014 Jul; 735():10-6. PubMed ID: 24751714
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of some xanthone derivatives for anti-arrhythmic, hypotensive properties and their affinity for adrenergic receptors.
Marona H; Szkaradek N; Kubacka M; Bednarski M; Filipek B; Cegla M; Szneler E
Arch Pharm (Weinheim); 2008 Feb; 341(2):90-8. PubMed ID: 18240129
[TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic and antihypertensive activity of some xanthone derivatives.
Marona H; Librowski T; Cegła M; Erdoğan C; Sahin NO
Acta Pol Pharm; 2008; 65(3):383-90. PubMed ID: 18646559
[TBL] [Abstract][Full Text] [Related]
6. Antiarrhythmic activity of some xanthone derivatives with β1-adrenoceptor affinities in rats.
Rapacz A; Sapa J; Bednarski M; Filipek B; Szkaradek N; Marona H
Eur J Pharmacol; 2014 Sep; 738():14-21. PubMed ID: 24876055
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxypropyl]-pyrrolidin-2-one derivatives with anti-arrhythmic, hypotensive, and alpha-adrenolytic activity.
Kulig K; Sapa J; Maciag D; Filipek B; Malawska B
Arch Pharm (Weinheim); 2007 Sep; 340(9):466-75. PubMed ID: 17806129
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological evaluation of new 1-[3-(4-phenylpiperazin-1-yl)-propyl]- and 1-[3-(4-phenylpiperidine)-propyl]- 3-aryl-3-alkyl-pyrrolidin-2-one derivatives with antiarrhythmic and antihypertensive activity.
Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
Acta Pol Pharm; 2009; 66(6):649-62. PubMed ID: 20050529
[TBL] [Abstract][Full Text] [Related]
10. Preliminary evaluation of pharmacological properties of some xanthone derivatives.
Marona H; Szkaradek N; Rapacz A; Filipek B; Dybała M; Siwek A; Cegła M; Szneler E
Bioorg Med Chem; 2009 Feb; 17(3):1345-52. PubMed ID: 19131251
[TBL] [Abstract][Full Text] [Related]
11. Antiarrhythmic and hypotensive activities of 1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-pyrrolidin-2-one (MG-1(R,S)) and its enantiomers.
Sapa J; Filipek B; Nowiński L
Pharmacol Rep; 2011; 63(2):455-63. PubMed ID: 21602601
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and development of new 2-substituted 1-[3-(4-arylpiperazin-1-yl)propyl]-pyrrolidin-2-one derivatives with antiarrhythmic, hypotensive, and alpha-adrenolytic activity.
Malawska B; Kulig K; Gippert A; Filipek B; Sapa J; Maciag D
Farmaco; 2005 Oct; 60(10):793-803. PubMed ID: 16181628
[TBL] [Abstract][Full Text] [Related]
13. Chiral 2-amino-1-butanol xanthone derivatives as potential antiarrhythmic and hypotensive agents.
Librowski T; Czarnecki R; Jastrzebska M
Acta Pol Pharm; 1999; 56(1):87-90. PubMed ID: 10635353
[No Abstract] [Full Text] [Related]
14. Synthesis and properties of some aminoalkanolic derivatives of xanthone.
Marona H; Szneler E; Filipek B; Sapa J
Acta Pol Pharm; 1997; 54(1):63-70. PubMed ID: 9415200
[TBL] [Abstract][Full Text] [Related]
15. Chemically Homogenous Compounds with Antagonistic Properties at All α1-Adrenoceptor Subtypes but not β1-Adrenoceptor Attenuate Adrenaline-Induced Arrhythmia in Rats.
Pytka K; Lustyk K; Żmudzka E; Kotańska M; Siwek A; Zygmunt M; Dziedziczak A; Śniecikowska J; Olczyk A; Gałuszka A; Śmieja J; Waszkielewicz AM; Marona H; Filipek B; Sapa J; Mogilski S
Front Pharmacol; 2016; 7():229. PubMed ID: 27536240
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and cardiovascular evaluation of some aminoisopropanoloxy derivatives of xanthone.
Kubacka M; Szkaradek N; Mogilski S; Pańczyk K; Siwek A; Gryboś A; Filipek B; Żmudzki P; Marona H; Waszkielewicz AM
Bioorg Med Chem; 2018 Jul; 26(13):3773-3784. PubMed ID: 29706529
[TBL] [Abstract][Full Text] [Related]
17. The Antiarrhythmic and Hypotensive Effects of S-61 and S-73, the Pyrrolidin-2-one Derivatives with α
Lustyk K; Sałaciak K; Siwek A; Sapa J; Zaręba P; Gałuszka A; Pytka K
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142287
[TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic properties of phenylpiperazine derivatives of phenytoin with α₁-adrenoceptor affinities.
Handzlik J; Bajda M; Zygmunt M; Maciąg D; Dybała M; Bednarski M; Filipek B; Malawska B; Kieć-Kononowicz K
Bioorg Med Chem; 2012 Apr; 20(7):2290-303. PubMed ID: 22381672
[TBL] [Abstract][Full Text] [Related]
19. Novel Arylpiperazine Derivatives of Salicylamide with α
Żmudzka E; Lustyk K; Siwek A; Wolak M; Gałuszka A; Jaśkowska J; Kołaczkowski M; Sapa J; Pytka K
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613736
[TBL] [Abstract][Full Text] [Related]
20. Antiarrhythmic activity of new 2-methoxyphenylpiperazine xanthone derivatives after ischemia/reperfusion in rats.
Rapacz A; Sapa J; Pytka K; Dudek M; Filipek B; Szkaradek N; Marona H
Pharmacol Rep; 2015 Dec; 67(6):1163-7. PubMed ID: 26481536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
